相关实验视频

Updated: Jul 29, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

[CIC重组瘤:对四例病例的临床病理学分析]

X Wan¹, J L Tang¹, X Li¹

¹Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

Zhonghua bing li xue za zhi = Chinese journal of pathology

|July 6, 2023

概括

CIC重组瘤 (CRS) 是一种罕见的癌症,具有攻击性行为和不良预后. 准确的诊断需要进行分子测试,因为它与其他类型的瘤具有重叠的特征.

科学领域:

在瘤学瘤学.
病理学病理学病理学
分子诊断学分子诊断

背景情况:

CIC重组瘤 (CRS) 是一种不常见的软组织瘤.
它的临床病理特征可以模仿其他类型的肉瘤,造成诊断挑战.

研究的目的:

为了研究CIC重组肉瘤的临床病理特征.
要突出CRS的差异诊断考虑因素.
为了强调分子确认的重要性.

主要方法:

从四名患者中对五例CRS病例进行了回顾性分析.
评估包括临床数据,H&E染色,免疫组织化学和分子分析.
相关案件的文献审查.

主要成果:

病例呈现出可变形态,包括圆形,卵形,状或上皮状细胞,通常具有状特征.
在大多数情况下,免疫组织化学显示出可变的CD99阳性和一致的WT1和TLE-1阳性.
所有病例通过分子检测证实有CIC重组; 临床过程是积极的,转移频繁,存活率差.

结论:

CIC重组瘤是一种罕见的实体,具有积极的临床过程和不良预后.
形态和免疫组织化学特征与其他瘤重叠,需要分子确认.
早期和准确的诊断对于适当的患者管理至关重要.

更多相关视频

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

相关概念视频

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...